Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-4-5
pubmed:databankReference
pubmed:abstractText
Many surgeons are reluctant to use esophageal stents during neoadjuvant therapy for esophageal cancer because of concerns about nutritional status, stent-related complications, or added difficulties during esophagogastrectomy. We hypothesized that esophageal stenting during neoadjuvant therapy allows for optimal nutritional intake without adversely affecting perioperative outcomes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1879-1190
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 American College of Surgeons. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
212
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
582-8; discussion 588-9
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
pubmed:affiliation
Department of Surgery, Division of Surgical Oncology, University of Louisville, Louisville, KY 40206, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Phase II